Millennium Management
EPRS

Millennium Management’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

Millennium Management’s Portfolio EPRS Stock Details EPRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-411,111
Closed -$1.11M – 3965
2016
Q1 		$1.11M Sell
411,111
-29,143
-7% -$81.8K ﹤0.01% 2131
2015
Q4 		$1.36M Sell
440,254
-30,986
-7% -$140K ﹤0.01% 2150
2015
Q3 		$2.08M Buy
471,240
+378,951
+411% +$2.23M ﹤0.01% 1877
2015
Q2 		$527K Buy
92,289
+36,515
+65% +$249K ﹤0.01% 2618
2015
Q1 		$499K Buy
+55,774
New +$448K ﹤0.01% 2759

Other funds holding EPRS

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return